A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Counties are facing limited supplies or no stock at all, leaving newborns vulnerable to TB. Health advocates are urging the ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...